Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0807 EUR | -0.37% | -8.19% | +12.24% |
Mar. 29 | Neolife SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Neolife SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Capitalization 1 | 2.878 | 6.866 | 23.36 | 16.13 | 3.687 |
Enterprise Value (EV) 1 | 3.787 | 7.143 | 23.31 | 17 | 4.341 |
P/E ratio | -1.43 x | -8.1 x | -45.2 x | -95.3 x | -1.87 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 0.4 x | 0.79 x | 2.88 x | 1.46 x | 0.27 x |
EV / Revenue | 0.53 x | 0.83 x | 2.87 x | 1.53 x | 0.32 x |
EV / EBITDA | -4.65 x | -15.6 x | 68.8 x | 118 x | -4.85 x |
EV / FCF | -9.73 x | -18.3 x | 55.1 x | -15.6 x | -7.71 x |
FCF Yield | -10.3% | -5.47% | 1.82% | -6.41% | -13% |
Price to Book | 1.73 x | 3.27 x | 10.9 x | 7.24 x | 1.41 x |
Nbr of stocks (in thousands) | 28,783 | 42,382 | 51,687 | 52,378 | 52,378 |
Reference price 2 | 0.1000 | 0.1620 | 0.4520 | 0.3080 | 0.0704 |
Announcement Date | 6/25/20 | 6/25/20 | 4/5/22 | 4/5/22 | 4/28/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales 1 | 7.198 | 8.655 | 8.126 | 11.09 | 13.59 |
EBITDA 1 | -0.8147 | -0.4572 | 0.3389 | 0.1444 | -0.8945 |
EBIT 1 | -1.482 | -0.6331 | -0.3414 | 0.008702 | -1.03 |
Operating Margin | -20.59% | -7.32% | -4.2% | 0.08% | -7.58% |
Earnings before Tax (EBT) 1 | -1.715 | -0.8135 | -0.4076 | -0.0789 | -3.663 |
Net income 1 | -1.859 | -0.9307 | -0.5163 | -0.1693 | -3.625 |
Net margin | -25.83% | -10.75% | -6.35% | -1.53% | -26.66% |
EPS 2 | -0.0700 | -0.0200 | -0.0100 | -0.003233 | -0.0376 |
Free Cash Flow 1 | -0.3892 | -0.3907 | 0.4233 | -1.089 | -0.5632 |
FCF margin | -5.41% | -4.51% | 5.21% | -9.82% | -4.14% |
FCF Conversion (EBITDA) | - | - | 124.91% | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 6/25/20 | 6/25/20 | 4/5/22 | 4/5/22 | 4/28/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net Debt 1 | 0.91 | 0.28 | - | 0.86 | 0.65 |
Net Cash position 1 | - | - | 0.06 | - | - |
Leverage (Debt/EBITDA) | -1.115 x | -0.6055 x | - | 5.987 x | -0.7305 x |
Free Cash Flow 1 | -0.39 | -0.39 | 0.42 | -1.09 | -0.56 |
ROE (net income / shareholders' equity) | -99.8% | -42.4% | -22.4% | -7.76% | -103% |
ROA (Net income/ Total Assets) | -17.3% | -7.83% | -3.46% | 0.08% | -8.84% |
Assets 1 | 10.75 | 11.89 | 14.91 | -207.5 | 40.99 |
Book Value Per Share 2 | 0.0600 | 0.0500 | 0.0400 | 0.0400 | 0.0500 |
Cash Flow per Share 2 | 0.0100 | 0.0200 | 0.0600 | 0.0400 | 0.0100 |
Capex 1 | 0.52 | 0.46 | 0.45 | 0.84 | 0.36 |
Capex / Sales | 7.28% | 5.33% | 5.58% | 7.62% | 2.68% |
Announcement Date | 6/25/20 | 6/25/20 | 4/5/22 | 4/5/22 | 4/28/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+12.24% | 8.33M | |
+13.58% | 53.84B | |
+20.98% | 37.34B | |
+15.17% | 34.54B | |
-5.13% | 33.53B | |
+11.80% | 19.06B | |
+20.89% | 18.67B | |
+18.85% | 18.51B | |
+6.96% | 11.93B | |
+4.71% | 7.02B |
- Stock Market
- Equities
- ALNLF Stock
- Financials Neolife